Cargando…

Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin

Recombinant human soluble thrombomodulin (ART‐123) is an anticoagulant and anti‐inflammatory agent clinically used for treatment of disseminated intravascular coagulation. Preclinical studies have shown that ART‐123 reduces hepatic ischemia/reperfusion. Although ART‐123 may therefore have clinical b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burlage, Laura C., Bos, Sarah, Adelmeijer, Jelle, Sakai, Takumi, Porte, Robert J., Lisman, Ton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590179/ https://www.ncbi.nlm.nih.gov/pubmed/30067306 http://dx.doi.org/10.1002/lt.25318

Ejemplares similares

Elevated Plasma Levels of Cell‐Free DNA During Liver Transplantation Are Associated With Activation of Coagulation
por: von Meijenfeldt, Fien A., et al.
Publicado: (2018)

Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis
por: Lisman, Ton, et al.
Publicado: (2023)

Efficacy of pro‐ and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery
por: Bos, Sarah, et al.
Publicado: (2020)

Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation
por: Arshad, Freeha, et al.
Publicado: (2014)

Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis
por: Potze, Wilma, et al.
Publicado: (2014)

Evidence against a role for platelet-derived molecules in liver regeneration after partial hepatectomy in humans
por: Kirschbaum, Marc, et al.
Publicado: (2016)

In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis
por: Lisman, Ton, et al.
Publicado: (2018)

Normothermic machine perfusion of donor livers without the need for human blood products
por: Matton, Alix P. M., et al.
Publicado: (2018)

Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis
por: van den Boom, Bente P., et al.
Publicado: (2021)

Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
por: Blasi, Annabel, et al.
Publicado: (2020)

Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
por: Blasi, Annabel, et al.
Publicado: (2019)

Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin Inhibitor
por: Lisman, Ton, et al.
Publicado: (2021)

Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study
por: Werner, Maureen J. M., et al.
Publicado: (2020)

Global hemostatic status in patients with acute‐on‐chronic liver failure and septics without underlying liver disease
por: Lisman, Ton, et al.
Publicado: (2020)

VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure
por: Driever, Ellen G., et al.
Publicado: (2021)

Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases
por: Lisman, Ton, et al.
Publicado: (2017)

Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival
por: Blasi, Annabel, et al.
Publicado: (2019)

Early elevated serum gamma glutamyl transpeptidase after liver transplantation is associated with better survival
por: Alkozai, Edris M, et al.
Publicado: (2014)

Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Extended hypothermic oxygenated machine perfusion enables ex situ preservation of porcine livers for up to 24 hours
por: Brüggenwirth, Isabel M.A., et al.
Publicado: (2020)

High plasma soluble thrombomodulin levels indicated poor prognosis of decompensated liver cirrhosis: a prospective cohort study
por: Wei, Xinhuan, et al.
Publicado: (2022)

Enhanced effect of recombinant human soluble thrombomodulin by ultrasound irradiation in acute liver failure
por: Hoshino, Kota, et al.
Publicado: (2020)

Protective Effects of Recombinant Human Soluble Thrombomodulin on Lipopolysaccharide-Induced Acute Kidney Injury
por: Nozaki, Yuji, et al.
Publicado: (2020)

Dynamics of Soluble Thrombomodulin and Circulating miRNAs in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation
por: Namino, Fuminori, et al.
Publicado: (2019)

Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death
por: van Rijn, R., et al.
Publicado: (2017)

Elevated factor V activity and antigen levels in patients with Covid‐19 are related to disease severity and 30‐day mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021)

Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010)

Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients
por: Wożakowska-Kapłon, Beata, et al.
Publicado: (2010)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
por: Yamakawa, K, et al.
Publicado: (2014)

Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin
por: Katayama, Shinshu, et al.
Publicado: (2017)

Coagulofibrinolytic effects of recombinant soluble thrombomodulin in prolonged porcine cardiac arrest
por: Zhang, Boya, et al.
Publicado: (2023)

Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation
por: van den Berg, Tamar A. J., et al.
Publicado: (2021)

Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients
por: Miyoshi, Seigo, et al.
Publicado: (2014)

Effects of probucol on atherosclerotic plaque and soluble thrombomodulin in patients with coronary heart disease
por: Liu, Donghai, et al.
Publicado: (2018)

Dual Versus Single Oxygenated Hypothermic Machine Perfusion of Porcine Livers: Impact on Hepatobiliary and Endothelial Cell Injury
por: de Vries, Yvonne, et al.
Publicado: (2021)

Efficacy of recombinant thrombomodulin for DIC after deceased donor liver transplantation: a case report
por: Kimura, Koichi, et al.
Publicado: (2016)

Recombinant human soluble thrombomodulin and danaparoid combination anticoagulant therapy for disseminated intravascular coagulation in a child with streptococcal toxic shock syndrome: A case report
por: Kato, Yutaka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tdbh7oqfav6628rdhe7o8a0u8b